[go: up one dir, main page]

 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (88)

Search Parameters:
Keywords = medical ontology

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
26 pages, 3120 KiB  
Article
Multi-Omics Analysis Revealed the rSNPs Potentially Involved in T2DM Pathogenic Mechanism and Metformin Response
by Igor S. Damarov, Elena E. Korbolina, Elena Y. Rykova and Tatiana I. Merkulova
Int. J. Mol. Sci. 2024, 25(17), 9297; https://doi.org/10.3390/ijms25179297 - 27 Aug 2024
Viewed by 407
Abstract
The goal of our study was to identify and assess the functionally significant SNPs with potentially important roles in the development of type 2 diabetes mellitus (T2DM) and/or their effect on individual response to antihyperglycemic medication with metformin. We applied a bioinformatics approach [...] Read more.
The goal of our study was to identify and assess the functionally significant SNPs with potentially important roles in the development of type 2 diabetes mellitus (T2DM) and/or their effect on individual response to antihyperglycemic medication with metformin. We applied a bioinformatics approach to identify the regulatory SNPs (rSNPs) associated with allele-asymmetric binding and expression events in our paired ChIP-seq and RNA-seq data for peripheral blood mononuclear cells (PBMCs) of nine healthy individuals. The rSNP outcomes were analyzed using public data from the GWAS (Genome-Wide Association Studies) and Genotype-Tissue Expression (GTEx). The differentially expressed genes (DEGs) between healthy and T2DM individuals (GSE221521), including metformin responders and non-responders (GSE153315), were searched for in GEO RNA-seq data. The DEGs harboring rSNPs were analyzed using the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). We identified 14,796 rSNPs in the promoters of 5132 genes of human PBMCs. We found 4280 rSNPs to associate with both phenotypic traits (GWAS) and expression quantitative trait loci (eQTLs) from GTEx. Between T2DM patients and controls, 3810 rSNPs were detected in the promoters of 1284 DEGs. Based on the protein-protein interaction (PPI) network, we identified 31 upregulated hub genes, including the genes involved in inflammation, obesity, and insulin resistance. The top-ranked 10 enriched KEGG pathways for these hubs included insulin, AMPK, and FoxO signaling pathways. Between metformin responders and non-responders, 367 rSNPs were found in the promoters of 131 DEGs. Genes encoding transcription factors and transcription regulators were the most widely represented group and many were shown to be involved in the T2DM pathogenesis. We have formed a list of human rSNPs that add functional interpretation to the T2DM-association signals identified in GWAS. The results suggest candidate causal regulatory variants for T2DM, with strong enrichment in the pathways related to glucose metabolism, inflammation, and the effects of metformin. Full article
(This article belongs to the Special Issue Advances in Molecular Research of Diabetes Mellitus)
Show Figures

Figure 1

Figure 1
<p>Scheme of the main stages in the search for rSNPs and their further analysis. The solid gray frame shows the stages of the search for rSNPs; the dotted gray frame, further analysis of the rSNP panel; and the cyan italic, data sources.</p>
Full article ">Figure 2
<p>Venn diagram showing the number of the rSNPs localized to allele-specific transcription factor binding sites (ANANASTRA), rSNPs associated phenotypic traits (GWAS data), and eQTLs effects (GTEx data).</p>
Full article ">Figure 3
<p>Volcano plot of DEGs. The horizontal axis stands for log2 fold change and the vertical axis, for –log<sub>10</sub> (adjusted <span class="html-italic">p</span>-value). Statistically significant DEGs harboring rSNPs in their promoters are marked red.</p>
Full article ">Figure 4
<p>Network chart illustrating the link of top ten significant KEGG pathways according to the enrichment analysis with upregulated hub genes.</p>
Full article ">Figure 5
<p>PPI network in the significant modules analyzed for KEGG and GO enrichment. (<b>A</b>) First module. (<b>B</b>) Second module. (<b>C</b>) Third module. In the PPI network, nodes show proteins and edges, their interaction. Hub proteins are denoted with larger symbols and the KEGG- and GO-annotated proteins, with the corresponding color (see the legend).</p>
Full article ">Figure 6
<p>Graphical visualization of DEG representation in (<b>A</b>) insulin and (<b>B</b>) PI3K/Akt signaling pathways (KEGG data). Colors of nodes show the direction and value (log2FC) of expression alteration.</p>
Full article ">Figure 6 Cont.
<p>Graphical visualization of DEG representation in (<b>A</b>) insulin and (<b>B</b>) PI3K/Akt signaling pathways (KEGG data). Colors of nodes show the direction and value (log2FC) of expression alteration.</p>
Full article ">Figure 7
<p>Volcano plot of DEGs. The horizontal axis shows the log<sub>2</sub> fold change and the vertical axis, –log<sub>10</sub> (adjusted <span class="html-italic">p</span>-value). Significant DEGs with detected rSNPs are colored red.</p>
Full article ">
31 pages, 11584 KiB  
Article
Enhancing Sustainability in Health Tourism through an Ontology-Based Booking Application for Personalized Packages
by Sofia Gkevreki, Vasiliki Fiska, Spiros Nikolopoulos and Ioannis Kompatsiaris
Sustainability 2024, 16(15), 6505; https://doi.org/10.3390/su16156505 - 30 Jul 2024
Viewed by 561
Abstract
Currently, health tourists primarily rely on independent facilitators to manage and book their medical appointments and vacation plans. There is a notable absence of dedicated booking applications for health tourism packages. This paper proposes HealthTourismHub, an application designed to provide personalized packages that [...] Read more.
Currently, health tourists primarily rely on independent facilitators to manage and book their medical appointments and vacation plans. There is a notable absence of dedicated booking applications for health tourism packages. This paper proposes HealthTourismHub, an application designed to provide personalized packages that include medical appointments, accommodation options, and recommended tourism activities. It also serves as a platform for medical experts and accommodation providers, allowing health tourists to discover and connect with them, promoting local resources, and contributing to the sustainable growth of health tourism destinations. To incorporate personalization, HealthTourismHub uses an ontology that organizes medical and tourism data, along with a reasoner that generates new knowledge. This approach enables the application to offer customized packages and identify the most suitable providers for each user. Providers are strategically paired and located in close proximity, encouraging shorter travel distances and more efficient travel planning, with the package also including personalized tourism recommendations that benefit the local economy and contribute to a conscious tourism industry. A survey was conducted to assess the usability of the application and general perspectives towards health tourism, including motivations, concerns, and preferences. The results revealed an above-average SUS score, indicating that users found the application user-friendly and effective. Some areas for improvement were identified, such as error handling and additional functionalities. Nonetheless, HealthTourismHub shows great potential as a pioneer in the field of sustainable health tourism applications. Full article
(This article belongs to the Collection Sustainable Health Tourism)
Show Figures

Figure 1

Figure 1
<p>The three user roles of the HTH application.</p>
Full article ">Figure 2
<p>Profile creation for HTPs.</p>
Full article ">Figure 3
<p>Booking form.</p>
Full article ">Figure 4
<p>Booking results.</p>
Full article ">Figure 5
<p>Package details: Overview, Medical info, Accommodation info, and Activities.</p>
Full article ">Figure 6
<p>Profile creation for MEs.</p>
Full article ">Figure 7
<p>Embedded map feature.</p>
Full article ">Figure 8
<p>Profile creation for APs.</p>
Full article ">Figure 9
<p>Flowchart of the application.</p>
Full article ">Figure 10
<p>Technology–stack architecture.</p>
Full article ">Figure 11
<p>Main classes of the ontology.</p>
Full article ">Figure 12
<p>The provider class.</p>
Full article ">Figure 13
<p>Graphical representation of the main AP relationships. Solid lines indicate subclass relationships.</p>
Full article ">Figure 14
<p>Classes associated with the AP class (<b>a</b>) AccommodationAmenity subclasses; (<b>b</b>) AccommodationFeature subclasses.</p>
Full article ">Figure 15
<p>Graphical representation of the main ME relationships. Solid lines indicate subclass relationships.</p>
Full article ">Figure 16
<p>Classes associated with the ME class (<b>a</b>) MedicalSpecialty subclasses; (<b>b</b>) MedicalService subclasses.</p>
Full article ">Figure 17
<p>Graphical representation of the Place class. Solid lines indicate subclass relationships, and the green box highlights the class being presented.</p>
Full article ">Figure 18
<p>Graphical representation of the Activity class. Solid lines indicate subclass relationships, and the green box highlights the class being presented.</p>
Full article ">Figure 19
<p>Building the HTH packages.</p>
Full article ">Figure 20
<p>HT package presentation.</p>
Full article ">Figure 21
<p>What would motivate the HTPs to consider HT.</p>
Full article ">Figure 22
<p>Main reasons HTPs would avoid HT.</p>
Full article ">Figure 23
<p>What HTPs would consider an all-inclusive HT package.</p>
Full article ">Figure 24
<p>Tourism options HTPs would consider if traveling for HT: (<b>a</b>) Activities; (<b>b</b>) Landscape; (<b>c</b>) Places they would visit.</p>
Full article ">Figure 25
<p>Most important features in an HT application.</p>
Full article ">Figure 26
<p>SUS scores on each question.</p>
Full article ">
21 pages, 3963 KiB  
Article
Empowering Clinical Engineering and Evidence-Based Maintenance with IoT and Indoor Navigation
by Alessio Luschi, Giovanni Luca Daino, Gianpaolo Ghisalberti, Vincenzo Mezzatesta and Ernesto Iadanza
Future Internet 2024, 16(8), 263; https://doi.org/10.3390/fi16080263 - 25 Jul 2024
Viewed by 732
Abstract
The OHIO (Odin Hospital Indoor cOmpass) project received funding from the European Union’s Horizon 2020 research and innovation action program, via ODIN–Open Call, which is issued and executed under the ODIN project and focuses on enhancing hospital safety, productivity, and quality by introducing [...] Read more.
The OHIO (Odin Hospital Indoor cOmpass) project received funding from the European Union’s Horizon 2020 research and innovation action program, via ODIN–Open Call, which is issued and executed under the ODIN project and focuses on enhancing hospital safety, productivity, and quality by introducing digital solutions, such as the Internet of Things (IoT), robotics, and artificial intelligence (AI). OHIO aims to enhance the productivity and quality of medical equipment maintenance activities within the pilot hospital, “Le Scotte” in Siena (Italy), by leveraging internal informational resources. OHIO will also be completely integrated with the ODIN platform, taking advantage of the available services and functionalities. OHIO exploits Bluetooth Low Energy (BLE) tags and antennas together with the resources provided by the ODIN platform to develop a complex ontology-based IoT framework, which acts as a central cockpit for the maintenance of medical equipment through a central management web application and an indoor real-time location system (RTLS) for mobile devices. The application programmable interfaces (APIs) are based on REST architecture for seamless data exchange and integration with the hospital’s existing computer-aided facility management (CAFM) and computerized maintenance management system (CMMS) software. The outcomes of the project are assessed both with quantitative and qualitative methods, by evaluating key performance indicators (KPIs) extracted from the literature and performing a preliminary usability test on both the whole system and the graphic user interfaces (GUIs) of the developed applications. The test implementation demonstrates improvements in maintenance timings, including a reduction in maintenance operation delays, duration of maintenance tasks, and equipment downtime. Usability post-test questionnaires show positive feedback regarding the usability and effectiveness of the applications. The OHIO framework enhanced the effectiveness of medical equipment maintenance by integrating existing software with newly designed, enhanced interfaces. The research also indicates possibilities for scaling up the developed methods and applications to additional large-scale pilot hospitals within the ODIN network. Full article
Show Figures

Figure 1

Figure 1
<p>A screen capture from SPOT.</p>
Full article ">Figure 2
<p>HiWay in off-site mode (<b>left</b>) allows saving custom routes for planning scopes, before reaching the premises. Routes can then be loaded once they arrive on-site and be used to obtain directions in real time (<b>middle</b> and <b>right</b>).</p>
Full article ">Figure 3
<p>Position of the installed BLE beacon on the ground floor of the hospital. The highlighted green area shows the good quality of the Bluetooth coverage.</p>
Full article ">Figure 4
<p>Fingerprinting quality for the RTLS. (<b>a</b>) Magnetic mapping quality. (<b>b</b>) WiFi environment quality. (<b>c</b>) Beacon environment quality.</p>
Full article ">Figure 5
<p>Schema of the ODIN platform.</p>
Full article ">Figure 6
<p>The ODIN ontology.</p>
Full article ">Figure 7
<p>Schema illustrating the communication among the various components of OHIO.</p>
Full article ">Figure 8
<p>OHIO management web application interface. The devices associated with the last two work orders are currently not collected in the EEH (the green check mark is missing).</p>
Full article ">Figure 9
<p>HiWay mobile application (1). (<b>a</b>) The collecting room code is highlighted in green, and the medical device the work order is referring to is placed inside that filter zone and can be accessed by the technician. (<b>b</b>) The navigation module shows the shortest route from the current position to the target room, enabling real-time navigation.</p>
Full article ">Figure 10
<p>HiWay mobile application (2). (<b>a</b>) The technician can access all the documents related to the inspected medical equipment by leveraging the connection between HiWay and the SPOT document manager. (<b>b</b>) Once a technician closes a work order, he is forced to select a fault class among the 10 available ones to classify the maintenance.</p>
Full article ">Figure 11
<p>User satisfaction questionnaire. Responses in a range from 1 (strongly disagree) to 5 (strongly agree) are evaluated as the frequency count and percentage obtained for each question.</p>
Full article ">
20 pages, 4107 KiB  
Article
Understanding the Foreign Body Response via Single-Cell Meta-Analysis
by Norah E. Liang, Jennifer B. Parker, John M. Lu, Michael Januszyk, Derrick C. Wan, Michelle Griffin and Michael T. Longaker
Biology 2024, 13(7), 540; https://doi.org/10.3390/biology13070540 - 18 Jul 2024
Viewed by 763
Abstract
Foreign body response (FBR) is a universal reaction to implanted biomaterial that can affect the function and longevity of the implant. A few studies have attempted to identify targets for treating FBR through the use of single-cell RNA sequencing (scRNA-seq), though the generalizability [...] Read more.
Foreign body response (FBR) is a universal reaction to implanted biomaterial that can affect the function and longevity of the implant. A few studies have attempted to identify targets for treating FBR through the use of single-cell RNA sequencing (scRNA-seq), though the generalizability of these findings from an individual study may be limited. In our study, we perform a meta-analysis of scRNA-seq data from all available FBR mouse studies and integrate these data to identify gene signatures specific to FBR across different models and anatomic locations. We identify subclusters of fibroblasts and macrophages that emerge in response to foreign bodies and characterize their signaling pathways, gene ontology terms, and downstream mediators. The fibroblast subpopulations enriched in the setting of FBR demonstrated significant signaling interactions in the transforming growth factor-beta (TGF-β) signaling pathway, with known pro-fibrotic mediators identified as top expressed genes in these FBR-derived fibroblasts. In contrast, FBR-enriched macrophage subclusters highly expressed pro-fibrotic and pro-inflammatory mediators downstream of tumor necrosis factor (TNF) signaling. Cell–cell interactions were additionally interrogated using CellChat, with identification of key signaling interactions enriched between fibroblasts and macrophages in FBR. By combining multiple FBR datasets, our meta-analysis study identifies common cell-specific gene signatures enriched in foreign body reactions, providing potential therapeutic targets for patients requiring medical implants across a myriad of devices and indications. Full article
Show Figures

Figure 1

Figure 1
<p>Meta-analysis workflow and data integration. (<b>A</b>) All publicly available foreign body response (FBR)-related single-cell RNA sequencing (scRNA-seq) datasets were identified by searching the Gene Expression Omnibus (GEO) and PubMed databases. The identified datasets were then manually screened for inclusion (green box) and exclusion (red box) criteria. (<b>B</b>) Schematic anatomic locations of the various FBR models included in the meta-analysis. (<b>C</b>) Experimental details associated with each GEO series [<a href="#B6-biology-13-00540" class="html-bibr">6</a>,<a href="#B7-biology-13-00540" class="html-bibr">7</a>,<a href="#B8-biology-13-00540" class="html-bibr">8</a>,<a href="#B9-biology-13-00540" class="html-bibr">9</a>]. (<b>D</b>) Uniform manifold approximation and projection (UMAP) of scRNA-seq data from all datasets included in the meta-analysis, colored according to cell type. (<b>E</b>) UMAP of scRNA-seq data from all datasets included in the meta-analysis, colored according to GEO accession number.</p>
Full article ">Figure 2
<p>Defining fibroblast subpopulations in FBR. (<b>A</b>) Uniform manifold approximation and projection (UMAP) of fibroblasts annotated in silico by differential expression of subcluster-defining genes (Pi16+, Timp1+, Col4a1+, Mmp3+, Fcer1g+, Stmn1+, Fmod+, Sfrp5+). (<b>B</b>) UMAP of fibroblasts colored according to expression levels of subpopulation-defining genes.</p>
Full article ">Figure 3
<p>Details of fibroblast subpopulations driving FBR. (<b>A</b>) Proportional distribution of fibroblast subclusters from FBR samples (left), surgery control samples (center), and tissue control samples (right). (<b>B</b>) Uniform manifold approximation and projection (UMAP) of fibroblasts colored by expression level for canonical fibroblast markers. (<b>C</b>) Violin plots displaying expression levels of the top five genes within each of the Pi16+, Col4a1+, and Mmp3+ fibroblast subclusters. Each violin plot additionally illustrates the expression level of each gene across all other fibroblast subpopulations (0 = PI16+, 1 = Timp1+, 2 = Col4a1+, 3 = Mmp3+, 4 = Fcer1g+, 5 = Stmn1+, 6 = Fmod+, 7 = Sfrp+).</p>
Full article ">Figure 4
<p>Defining macrophage subpopulations in FBR. (<b>A</b>) Uniform manifold approximation and projection (UMAP) of macrophages annotated in silico by differential expression of subcluster-defining genes (Bhlhe40+, Rbm42-, Ccl8+, Gpnmb+, Plac8+, Retnla+, Bnip3+). (<b>B</b>) UMAP of macrophages colored by expression level of subpopulation-defining genes.</p>
Full article ">Figure 5
<p>Detailing macrophage subpopulations driving FBR. (<b>A</b>) Proportional distribution of macrophage subclusters from FBR samples (left), surgery control samples (center), and tissue control samples (right). (<b>B</b>) Uniform manifold approximation and projection (UMAP) of macrophages colored by expression level for canonical macrophage markers. (<b>C</b>) Violin plots displaying expression levels of the top five genes within each of the Bhlhe40+, Rbm42-, and Bnip3+ macrophage subclusters. Each violin plot additionally illustrates the expression level of each gene across all other macrophage subpopulations. (0 = Bhlhe40+, 1 = Rbm42-, 2 = Ccl8+, 3 = Gpmb+, 4 = Plac8+, 5 = Retnla+, 6 = Bnip3+).</p>
Full article ">Figure 6
<p>CellChat analysis of FBR cell subpopulations. (<b>A</b>) Number (<b>left</b>) and strength (<b>right</b>) of cell–cell interaction maps among cells from FBR capsules. Arrows depict cell populations from which signaling originates, with arrowheads depicting cell populations to which signaling interactions are directed. Thicker lines denote a greater number of interactions (<b>left</b>) and greater interaction weight (<b>right</b>). (<b>B</b>) Chord diagram displaying all significant interactions between macrophages and fibroblasts. Thicker lines denote stronger interactions. (<b>C</b>) Inferred macrophage migration inhibitory factor (MIF) signaling network in all cells. Thicker lines denote stronger interactions, with arrows illustrating the direction of signaling between cell types. (<b>D</b>) Expression distribution across cell types of MIF signaling-associated genes, illustrated on the y-axis (Mif, Ackr3, Cd74, Cxcr4, Cd44). Cell types are illustrated on the x-axis. Violin plots correspond to the expression level of each MIF-pathway mediator gene by each individual cell type. (<b>E</b>) Inferred Semaphorin-3 (SEMA3) signaling network in all cells. Thicker lines denote stronger interactions, with arrows illustrating the direction of signaling between cell types. (<b>F</b>) Expression distribution across cell types of SEMA3 signaling-associated genes, illustrated on the y-axis (Sema3c, Sema3f, Plxnd1, Nrp1, Nrp2, Plxna2). Cell types are illustrated on the x-axis. Violin plots correspond to the expression level of each SEMA3-pathway mediator gene by each individual cell type.</p>
Full article ">
14 pages, 3543 KiB  
Article
Transforming Ontology Web Language Elements into Common Terminology Service 2 Terminology Resources
by Sara Mora, Roberta Gazzarata, Bernd Blobel, Ylenia Murgia and Mauro Giacomini
J. Pers. Med. 2024, 14(7), 676; https://doi.org/10.3390/jpm14070676 - 24 Jun 2024
Viewed by 745
Abstract
Communication and cooperation are fundamental for the correct deployment of P5 medicine, and this can be achieved only by correct comprehension of semantics so that it can aspire to medical knowledge sharing. There is a hierarchy in the operations that need to be [...] Read more.
Communication and cooperation are fundamental for the correct deployment of P5 medicine, and this can be achieved only by correct comprehension of semantics so that it can aspire to medical knowledge sharing. There is a hierarchy in the operations that need to be performed to achieve this goal that brings to the forefront the complete understanding of the real-world business system by domain experts using Domain Ontologies, and only in the last instance acknowledges the specific transformation at the pure information and communication technology level. A specific feature that should be maintained during such types of transformations is versioning that aims to record the evolution of meanings in time as well as the management of their historical evolution. The main tool used to represent ontology in computing environments is the Ontology Web Language (OWL), but it was not created for managing the evolution of meanings in time. Therefore, we tried, in this paper, to find a way to use the specific features of Common Terminology Service—Release 2 (CTS2) to perform consistent and validated transformations of ontologies written in OWL. The specific use case managed in the paper is the Alzheimer’s Disease Ontology (ADO). We were able to consider all of the elements of ADO and map them with CTS2 terminological resources, except for a subset of elements such as the equivalent class derived from restrictions on other classes. Full article
Show Figures

Figure 1

Figure 1
<p>Model and framework for representing multi-domain, knowledge-based, ontology-based, and policy-driven ecosystems.</p>
Full article ">Figure 2
<p>The CTS2 terminology resources and the detail of the EntityDescription elements considered in this paper.</p>
Full article ">Figure 3
<p>An example of an OWL class defined in ADO, with an indication of the corresponding CTS2 EntityDescription element in which every OWL element can be mapped.</p>
Full article ">Figure 4
<p>An extract from the EntityDescription “Behavioral therapies” defined in the ADOV1 contained in the SOAP message, intercepted as a response of the CTS2 operation Entity Description Read Service/read.</p>
Full article ">Figure 5
<p>An example of the tree visualization of ADO classes (<b>left</b>) and entity details (<b>right</b>).</p>
Full article ">Figure 6
<p>An example of a search for a name.</p>
Full article ">Figure 7
<p>Visualization of term information, annotation properties, and object properties.</p>
Full article ">Figure 8
<p>List of all MapEntries belonging to the MapCatalog identified by the two CodeSystems ADO and AdaLab, and more in detail, the two CodeSystemVersions named ADOV1 and AdaLab1.</p>
Full article ">
20 pages, 404 KiB  
Article
Soul as Principle in Plato’s Charmides: A Reading of Plato’s Anthropological Ontology Based on Hermias Alexandrinus on Plato’s Phaedrus
by Melina G. Mouzala
Philosophies 2024, 9(3), 77; https://doi.org/10.3390/philosophies9030077 - 26 May 2024
Viewed by 647
Abstract
This paper aims to interpret the role of the soul as ontological, intellectual or cognitive and as the moral principle within the frame of the holistic conception of human psychosomatic health that emerges from the context of Zalmoxian medicine in the proemium of [...] Read more.
This paper aims to interpret the role of the soul as ontological, intellectual or cognitive and as the moral principle within the frame of the holistic conception of human psychosomatic health that emerges from the context of Zalmoxian medicine in the proemium of Plato’s Charmides. It examines what the ontological status of the soul is in relation to the body and the body–soul complex of man considered as a psychosomatic whole. By comparing the presentation of the soul as principle in the Charmides and the Phaedrus, the paper defends the thesis that in the former dialogue, Plato develops his own anthropological ontology, which paves the way for the salvation of human existence and health. The soul is bestowed with an ontological primacy that determines the philosophical and medical presuppositions for treating human illness under a holistic view. The interpretation of the ontological relation of the soul to the body and the entire human being in the context of Zalmoxian holistic medicine is based on Hermias Alexandrinus’ exegesis of the conception of the soul as principle in the Phaedrus. This paper demonstrates that, from both the medical holistic viewpoint and the anthropological philosophical perspective, the soul is the principle and πρῶτον with regard to the body and the body–soul complex without being the whole that the corresponding medical epistemology must apprehend. Full article
(This article belongs to the Special Issue Ancient and Medieval Theories of Soul)
14 pages, 2433 KiB  
Article
Automatic Classification and Visualization of Text Data on Rare Diseases
by Luis Rei, Joao Pita Costa and Tanja Zdolšek Draksler
J. Pers. Med. 2024, 14(5), 545; https://doi.org/10.3390/jpm14050545 - 20 May 2024
Viewed by 823
Abstract
More than 7000 rare diseases affect over 400 million people, posing significant challenges for medical research and healthcare. The integration of precision medicine with artificial intelligence offers promising solutions. This work introduces a classifier developed to discern whether research and news articles pertain [...] Read more.
More than 7000 rare diseases affect over 400 million people, posing significant challenges for medical research and healthcare. The integration of precision medicine with artificial intelligence offers promising solutions. This work introduces a classifier developed to discern whether research and news articles pertain to rare or non-rare diseases. Our methodology involves extracting 709 rare disease MeSH terms from Mondo and MeSH to improve rare disease categorization. We evaluate our classifier on abstracts from PubMed/MEDLINE and an expert-annotated news dataset, which includes news articles on four selected rare neurodevelopmental disorders (NDDs)—considered the largest category of rare diseases—from a total of 16 analyzed. We achieved F1 scores of 85% for abstracts and 71% for news articles, demonstrating robustness across both datasets and highlighting the potential of integrating artificial intelligence and ontologies to improve disease classification. Although the results are promising, they also indicate the need for further refinement in managing data heterogeneity. Our classifier improves the identification and categorization of medical information, essential for advancing research, enhancing information access, influencing policy, and supporting personalized treatments. Future work will focus on expanding disease classification to distinguish between attributes such as infectious and hereditary diseases, addressing data heterogeneity, and incorporating multilingual capabilities. Full article
(This article belongs to the Special Issue Artificial Intelligence and Data Integration in Precision Health)
Show Figures

Figure 1

Figure 1
<p>Architecture of the classifier model, where the transformer encoder and the classification head are the main blocks, in bold, and only the output of the start token will pass to the classifier.</p>
Full article ">Figure 2
<p>Confusion matrices.</p>
Full article ">Figure 3
<p>The MeSH classifier for health-related documents.</p>
Full article ">Figure 4
<p>The application of the framework to the exploration of health news.</p>
Full article ">Figure 5
<p>The data exploration tool allowing prototyping by health experts.</p>
Full article ">
26 pages, 8814 KiB  
Article
Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation Analysis Reveal Insights into the Molecular Mechanism of Cordia myxa in the Treatment of Liver Cancer
by Li Li, Alaulddin Hazim Mohammed, Nazar Aziz Auda, Sarah Mohammed Saeed Alsallameh, Norah A. Albekairi, Ziyad Tariq Muhseen and Christopher J. Butch
Biology 2024, 13(5), 315; https://doi.org/10.3390/biology13050315 - 1 May 2024
Viewed by 2244
Abstract
Traditional treatments of cancer have faced various challenges, including toxicity, medication resistance, and financial burdens. On the other hand, bioactive phytochemicals employed in complementary alternative medicine have recently gained interest due to their ability to control a wide range of molecular pathways while [...] Read more.
Traditional treatments of cancer have faced various challenges, including toxicity, medication resistance, and financial burdens. On the other hand, bioactive phytochemicals employed in complementary alternative medicine have recently gained interest due to their ability to control a wide range of molecular pathways while being less harmful. As a result, we used a network pharmacology approach to study the possible regulatory mechanisms of active constituents of Cordia myxa for the treatment of liver cancer (LC). Active constituents were retrieved from the IMPPAT database and the literature review, and their targets were retrieved from the STITCH and Swiss Target Prediction databases. LC-related targets were retrieved from expression datasets (GSE39791, GSE76427, GSE22058, GSE87630, and GSE112790) through gene expression omnibus (GEO). The DAVID Gene Ontology (GO) database was used to annotate target proteins, while the Kyoto Encyclopedia and Genome Database (KEGG) was used to analyze signaling pathway enrichment. STRING and Cytoscape were used to create protein–protein interaction networks (PPI), while the degree scoring algorithm of CytoHubba was used to identify hub genes. The GEPIA2 server was used for survival analysis, and PyRx was used for molecular docking analysis. Survival and network analysis revealed that five genes named heat shot protein 90 AA1 (HSP90AA1), estrogen receptor 1 (ESR1), cytochrome P450 3A4 (CYP3A4), cyclin-dependent kinase 1 (CDK1), and matrix metalloproteinase-9 (MMP9) are linked with the survival of LC patients. Finally, we conclude that four extremely active ingredients, namely cosmosiin, rosmarinic acid, quercetin, and rubinin influence the expression of HSP90AA1, which may serve as a potential therapeutic target for LC. These results were further validated by molecular dynamics simulation analysis, which predicted the complexes with highly stable dynamics. The residues of the targeted protein showed a highly stable nature except for the N-terminal domain without affecting the drug binding. An integrated network pharmacology and docking study demonstrated that C. myxa had a promising preventative effect on LC by working on cancer-related signaling pathways. Full article
Show Figures

Figure 1

Figure 1
<p>Graphical representation of the workflow of this study.</p>
Full article ">Figure 2
<p>Compound–target network of 173 common targets of 10 active compounds. Blue color represents the compounds, and yellow color represents the targets.</p>
Full article ">Figure 3
<p>Volcano plots of DEGs. (<b>A</b>) GSE39791, (<b>B</b>) GSE76427, (<b>C</b>) GSE22058, (<b>D</b>) GSE87630, and (<b>E</b>) GSE112790. Blue and red colors represent down-regulated and up-regulated genes, respectively. (<b>F</b>) With a total of 173 overlapping genes, the Venn diagram shows the targets of <span class="html-italic">C. myxa</span> and LC.</p>
Full article ">Figure 4
<p>(<b>A</b>–<b>D</b>) depicts a bubble chart of the top 20 enriched GO terms (BP, CC, MF) and KEGG pathways, respectively.</p>
Full article ">Figure 5
<p>(<b>A</b>) Ten hub genes based on degree. (<b>B</b>) Bar chart of 10 hub genes. (<b>C</b>) Co-expression of hub genes in Homo sapiens.</p>
Full article ">Figure 6
<p>Compound/drug–target–pathways network. The orange V shapes represent the active constituents/drugs associated with hub genes, the green circles represent hub genes, and the cyan triangles represent the pathways linked to the hub genes.</p>
Full article ">Figure 7
<p>The GEPIA 2 was used to evaluate the survival data of the hub genes including (<b>A</b>) ALB, (<b>B</b>) IL6, (<b>C</b>) HSP90AA1, (<b>D</b>) ESR1, (<b>E</b>) CYP3A4, (<b>F</b>) PTGS2, (<b>G</b>) TLR4, (<b>H</b>) CDK1, (<b>I</b>) MMP9, and (<b>J</b>) CYP1A1. The red line shows patients with expression levels above the median, whereas the black line reflects expression levels below the median. HR stands for the hazard ratio.</p>
Full article ">Figure 8
<p>Docking position and interactions of 3 highly bounded compounds with HSP90AA1.</p>
Full article ">Figure 9
<p>(<b>A</b>) RMSD, (<b>B</b>) RMSF, (<b>C</b>) RoG, and (<b>D</b>) Beta Factor plots for the complexes.</p>
Full article ">Figure 10
<p>SASA analysis for the studied complexes.</p>
Full article ">
23 pages, 679 KiB  
Article
Developing a Novel Ontology for Cybersecurity in Internet of Medical Things-Enabled Remote Patient Monitoring
by Kulsoom S. Bughio, David M. Cook and Syed Afaq A. Shah
Sensors 2024, 24(9), 2804; https://doi.org/10.3390/s24092804 - 27 Apr 2024
Cited by 1 | Viewed by 1263
Abstract
IoT has seen remarkable growth, particularly in healthcare, leading to the rise of IoMT. IoMT integrates medical devices for real-time data analysis and transmission but faces challenges in data security and interoperability. This research identifies a significant gap in the existing literature regarding [...] Read more.
IoT has seen remarkable growth, particularly in healthcare, leading to the rise of IoMT. IoMT integrates medical devices for real-time data analysis and transmission but faces challenges in data security and interoperability. This research identifies a significant gap in the existing literature regarding a comprehensive ontology for vulnerabilities in medical IoT devices. This paper proposes a fundamental domain ontology named MIoT (Medical Internet of Things) ontology, focusing on cybersecurity in IoMT (Internet of Medical Things), particularly in remote patient monitoring settings. This research will refer to similar-looking acronyms, IoMT and MIoT ontology. It is important to distinguish between the two. IoMT is a collection of various medical devices and their applications within the research domain. On the other hand, MIoT ontology refers to the proposed ontology that defines various concepts, roles, and individuals. MIoT ontology utilizes the knowledge engineering methodology outlined in Ontology Development 101, along with the structured life cycle, and establishes semantic interoperability among medical devices to secure IoMT assets from vulnerabilities and cyberattacks. By defining key concepts and relationships, it becomes easier to understand and analyze the complex network of information within the IoMT. The MIoT ontology captures essential key terms and security-related entities for future extensions. A conceptual model is derived from the MIoT ontology and validated through a case study. Furthermore, this paper outlines a roadmap for future research, highlighting potential impacts on security automation in healthcare applications. Full article
(This article belongs to the Section Internet of Things)
Show Figures

Figure 1

Figure 1
<p>Class diagram for the concept classification trees.</p>
Full article ">Figure 2
<p>The Conceptual model of MIoT ontology.</p>
Full article ">Figure 3
<p>The granularity of MIoT ontology described for the concept <span class="html-italic">Product</span> with subclasses, instances, and relationship.</p>
Full article ">
14 pages, 5607 KiB  
Article
In Silico and In Vitro Study of Isoquercitrin against Kidney Cancer and Inflammation by Triggering Potential Gene Targets
by Safia Iqbal, Md. Rezaul Karim, Shahnawaz Mohammad, Jong Chan Ahn, Anjali Kariyarath Valappil, Ramya Mathiyalagan, Deok-Chun Yang, Dae-Hyo Jung, Hyocheol Bae and Dong Uk Yang
Curr. Issues Mol. Biol. 2024, 46(4), 3328-3341; https://doi.org/10.3390/cimb46040208 - 12 Apr 2024
Viewed by 1342
Abstract
Kidney cancer has emerged as a major medical problem in recent times. Multiple compounds are used to treat kidney cancer by triggering cancer-causing gene targets. For instance, isoquercitrin (quercetin-3-O-β-d-glucopyranoside) is frequently present in fruits, vegetables, medicinal herbs, and foods and drinks made from [...] Read more.
Kidney cancer has emerged as a major medical problem in recent times. Multiple compounds are used to treat kidney cancer by triggering cancer-causing gene targets. For instance, isoquercitrin (quercetin-3-O-β-d-glucopyranoside) is frequently present in fruits, vegetables, medicinal herbs, and foods and drinks made from plants. Our previous study predicted using protein-protein interaction (PPI) and molecular docking analysis that the isoquercitrin compound can control kidney cancer and inflammation by triggering potential gene targets of IGF1R, PIK3CA, IL6, and PTGS2. So, the present study is about further in silico and in vitro validation. We performed molecular dynamic (MD) simulation, gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, cytotoxicity assay, and RT-PCR and qRT-PCR validation. According to the MD simulation (250 ns), we found that IGF1R, PIK3CA, and PTGS2, except for IL6 gene targets, show stable binding energy with a stable complex with isoquercitrin. We also performed gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses of the final targets to determine their regulatory functions and signaling pathways. Furthermore, we checked the cytotoxicity effect of isoquercitrin (IQ) and found that 5 μg/mL and 10 μg/mL doses showed higher cell viability in a normal kidney cell line (HEK 293) and also inversely showed an inhibition of cell growth at 35% and 45%, respectively, in the kidney cancer cell line (A498). Lastly, the RT-PCR and qRT-PCR findings showed a significant decrease in PTGS2, PIK3CA, and IGF1R gene expression, except for IL6 expression, following dose-dependent treatments with IQ. Thus, we can conclude that isoquercitrin inhibits the expression of PTGS2, PIK3CA, and IGF1R gene targets, which in turn controls kidney cancer and inflammation. Full article
(This article belongs to the Special Issue Natural Products in Biomedicine and Pharmacotherapy)
Show Figures

Figure 1

Figure 1
<p>Chemical structure of isoquercitrin and its gene targets.</p>
Full article ">Figure 2
<p>Molecular dynamic simulation (Part-1). (<b>A</b>) RMSD and (<b>B</b>) RMSF. RMSD—root-mean-square deviation; RMSF—root-mean-square fluctuation. (Desmond v6.3 Program in Schrödinger 2023-3 under the Linux platform was used for this simulation).</p>
Full article ">Figure 2 Cont.
<p>Molecular dynamic simulation (Part-1). (<b>A</b>) RMSD and (<b>B</b>) RMSF. RMSD—root-mean-square deviation; RMSF—root-mean-square fluctuation. (Desmond v6.3 Program in Schrödinger 2023-3 under the Linux platform was used for this simulation).</p>
Full article ">Figure 3
<p>Molecular dynamic simulation (Part 2): (<b>A</b>) radius of gyration (rGyr); (<b>B</b>) solvent–accessible surface area (SASA); and (<b>C</b>) protein–ligand contact from the MD simulation trajectory. (Desmond v6.3 Program in Schrödinger 2023-3 under the Linux platform was used for this simulation).</p>
Full article ">Figure 4
<p>Gene ontology (GO) and KEGG pathway analysis of the target genes. (<b>A</b>) Biological process. (<b>B</b>) Molecular functions. (<b>C</b>) Cellular components. (<b>D</b>) KEGG pathway analysis.</p>
Full article ">Figure 5
<p>MTT assay to determine cell viability percentage. (<b>A</b>) HEK 293 normal kidney cell treatment with different doses of isoquercitrin (IQ); (<b>B</b>) A493 kidney cancer cell line treated with cisplatin and isoquercitrin (IQ). ** <span class="html-italic">p</span> &lt; 0.001 indicates significant differences from control groups.</p>
Full article ">Figure 6
<p>Impacts of isoquercitrin (IQ) and cisplatin on the cDNA expression levels of genes linked to kidney cancer and inflammation in A498 cells. (<b>A</b>) RT-PCR and (<b>B</b>–<b>E</b>) qRT-PCR expression profile for targeted genes (control: without treatment, cisplatin: 10 μg/µL; and doses of IQ of 5 μg/µL and 10 μg/µL were applied for 24 h. Following the extraction of total RNA, we prepared cDNA then performed RT-PCR and qRT-PCR). For qRT–PCR, all results display the mean ± SE of duplicate samples from 3 independent experiments (* <span class="html-italic">p</span> &lt; 0.05 and ** <span class="html-italic">p</span> &lt; 0.01 using Student’s <span class="html-italic">t</span>-test compared to the non-treated control).</p>
Full article ">
18 pages, 2411 KiB  
Article
Learning from conect4children: A Collaborative Approach towards Standardisation of Disease-Specific Paediatric Research Data
by Anando Sen, Victoria Hedley, Eva Degraeuwe, Steven Hirschfeld, Ronald Cornet, Ramona Walls, John Owen, Peter N. Robinson, Edward G. Neilan, Thomas Liener, Giovanni Nisato, Neena Modi, Simon Woodworth, Avril Palmeri, Ricarda Gaentzsch, Melissa Walsh, Teresa Berkery, Joanne Lee, Laura Persijn, Kasey Baker, Kristina An Haack, Sonia Segovia Simon, Julius O. B. Jacobsen, Giorgio Reggiardo, Melissa A. Kirwin, Jessie Trueman, Claudia Pansieri, Donato Bonifazi, Sinéad Nally, Fedele Bonifazi, Rebecca Leary and Volker Straubadd Show full author list remove Hide full author list
Data 2024, 9(4), 55; https://doi.org/10.3390/data9040055 - 8 Apr 2024
Cited by 1 | Viewed by 2397
Abstract
The conect4children (c4c) initiative was established to facilitate the development of new drugs and other therapies for paediatric patients. It is widely recognised that there are not enough medicines tested for all relevant ages of the paediatric population. To overcome this, it is [...] Read more.
The conect4children (c4c) initiative was established to facilitate the development of new drugs and other therapies for paediatric patients. It is widely recognised that there are not enough medicines tested for all relevant ages of the paediatric population. To overcome this, it is imperative that clinical data from different sources are interoperable and can be pooled for larger post hoc studies. c4c has collaborated with the Clinical Data Interchange Standards Consortium (CDISC) to develop cross-cutting data resources that build on existing CDISC standards in an effort to standardise paediatric data. The natural next step was an extension to disease-specific data items. c4c brought together several existing initiatives and resources relevant to disease-specific data and analysed their use for standardising disease-specific data in clinical trials. Several case studies that combined disease-specific data from multiple trials have demonstrated the need for disease-specific data standardisation. We identified three relevant initiatives. These include European Reference Networks, European Joint Programme on Rare Diseases, and Pistoia Alliance. Other resources reviewed were National Cancer Institute Enterprise Vocabulary Services, CDISC standards, pharmaceutical company-specific data dictionaries, Human Phenotype Ontology, Phenopackets, Unified Registry for Inherited Metabolic Disorders, Orphacodes, Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP), and Observational Medical Outcomes Partnership. The collaborative partners associated with these resources were also reviewed briefly. A plan of action focussed on collaboration was generated for standardising disease-specific paediatric clinical trial data. A paediatric data standards multistakeholder and multi-project user group was established to guide the remaining actions—FAIRification of metadata, a Phenopackets pilot with RDCA-DAP, applying Orphacodes to case report forms of clinical trials, introducing CDISC standards into European Reference Networks, testing of the CDISC Pediatric User Guide using data from the mentioned resources and organisation of further workshops and educational materials. Full article
Show Figures

Figure 1

Figure 1
<p>The categorisations for the 13 initiatives and resources brought together by c4c for disease-specific standardisation.</p>
Full article ">Figure 2
<p>Exemplar relationships between select terminologies, data standards, and resources. The spheres of activity are designated by coloured boxes where yellow is research, grey is meta thesauri and mappings, light orange is regulatory activities, green is healthcare delivery (slightly darker for a sub-box of observations), and blue is reimbursement. The mappings are simplified and do not indicate the many levels of interactivity and potential interoperability.</p>
Full article ">Figure 3
<p>Schematic representation of the ongoing and proposed collaborations between large consortia, data resources and data standards and dictionaries. Ongoing collaborations are marked with black double-headed arrows. Single-headed blue arrows denote a smaller resource as part of a larger resource, which are together encapsulated in a box. The box labelled ‘Pharmaceutical companies’ stands for both industry data dictionaries as well as industries as a collective entity that conducts clinical trials. Red dashed arrows denote the collaborations proposed in the action points with the action number over the arrows. Action points 1 and 7 are shown as a red dashed box around the figure.</p>
Full article ">
20 pages, 5540 KiB  
Article
Transcriptional Profiling of BpWRKY49 Reveals Its Role as a Master Regulator in Stress Signaling Pathways in Birch (Betula platyphylla)
by Sammar Abbas, Ruotong Jing, Manzar Abbas, Zijian Hu, Rabia Kalsoom, Syed Sarfaraz Hussain, Liang Du, Jinxing Lin and Xi Zhang
Forests 2024, 15(4), 605; https://doi.org/10.3390/f15040605 - 27 Mar 2024
Viewed by 1010
Abstract
The WRKY family of transcription factors (TFs) is one of the most diverse families in plants, playing crucial roles in various plant growth and stress response processes. Asian white birch (Betula platyphylla) is a globally distributed tree species that holds ecological, [...] Read more.
The WRKY family of transcription factors (TFs) is one of the most diverse families in plants, playing crucial roles in various plant growth and stress response processes. Asian white birch (Betula platyphylla) is a globally distributed tree species that holds ecological, medical, and economic significance. However, the regulatory mechanisms of WRKY TFs in birch remain poorly understood. Herein, we cloned and characterized the BpWRKY49 gene from birch. Through bioinformatics analyses, we revealed the potential involvement of BpWRKY49 in both biotic and abiotic stress responses. In addition, BpWRKY49 was found to be localized in the nucleus and exhibited transcriptional activity in yeast. Transactivation assays further confirmed that BpWRKY49 exhibited transcriptional activity at its C-terminal end. Notably, our binding specificity assays demonstrated the specific interaction of BpWRKY49 with the W-box cis element in vitro. Furthermore, tissue-specific expression analysis demonstrated that BpWRKY49 exhibited the highest expression level in the roots. Real-time quantitative PCR (RT-qPCR) analysis of birch plants subjected to salt and drought treatments revealed that BpWRKY49 displayed significant 30-fold and 10-fold upregulations under salt and drought stress conditions, respectively. DAP-seq analysis of BpWRKY49 identified a total of 21,832 peaks, with 3477 occurring in the promoter region of genes. Gene ontology (GO) enrichment analysis highlighted prominent terms related to defense against biotic stress, followed by terms associated with abiotic stress and development. Y1H assays of three genes provided evidence for the binding ability of BpWRKY49 to the promoters of BpPUB21, BpBTL15, and BpHIP47 in vitro. Collectively, our findings strongly suggest that BpWRKY49 possesses diverse functions and may activate multiple genes to contribute to various biological processes, including salt stress tolerance, in birch. Full article
(This article belongs to the Section Genetics and Molecular Biology)
Show Figures

Figure 1

Figure 1
<p>Sequence, phylogenetic, and promoter analysis of BpWRKY49. (<b>a</b>) Sequence alignment of BpWRKY49 with WRKYs from other species. Identical amino acids are shaded black. Red underline shows WRKY domain sequence, left red line with arrow above shows WRKY heptapeptide and right red line above shows zinc finger domain with arrows showing two Cs, H, and C amino acid within the zinc-finger domain. (<b>b</b>) Phylogenetic tree of BpWRKY49 with other WRKYs, while WRKY with a star shows the position of BpWRKY49 in the tree. (<b>c</b>) Promoter of BpWRKY49 containing various cis-acting elements depicted as rectangular colored boxes, while the names of cis-acting elements are shown with square colored boxes.</p>
Full article ">Figure 2
<p>Expression analysis and binding of BpWRKY49 to W-box. (<b>a</b>) Tissue-specific expression of <span class="html-italic">BpWRKY49</span> in young leaves, young stem, mature leaves, mature stem, and roots. (<b>b</b>,<b>c</b>) Expression pattern of <span class="html-italic">BpWRKY49</span> during salt and drought treatment, respectively. Data are mean ± SD of three replicates. (<b>d</b>) Sequence of three tandem copies of Wbox and mWbox elements. (<b>e</b>) DNA-binding assay using the 3× W-box or mW-box as bait. Yeast transformants carrying pGADT7-BpWRKY49 were diluted to 10-fold, 50-fold, and 100-fold and then grown on SD/-Leu (<b>left</b>) and SD/-Leu containing 600 ng/mL AbA (<b>right</b>), respectively.</p>
Full article ">Figure 3
<p>Subcellular localization and transactivation assay for BpWRKY49. (<b>a</b>) Schematic representation of constructs used for transformation of tobacco leaves. (<b>b</b>) Subcellular localization assay of the BpWRKY49 protein. Images showing the cells expressing GFP (control, left lane) or BpWRKY49:GFP (right lane) fusion protein, examined under fluorescent-field illumination (first line), chloroplast illumination (second line); bright-field illumination (third line); and an overlay of fluorescent, chloroplast, and bright illumination (fourth line). Scale bars, 50 µm. (<b>c</b>) Schematic representation of construct used for transaction assay of full-length BpWRKY49 protein. (<b>d</b>) Construct was transformed into yeast AH109 strain and examined on SD/-Trp and SD/-Trp/-Leu/-Ade/X-α-gal plates. (<b>e</b>) Schematic representation of different truncated versions of BpWRKY49 used in transactivation experiment. (<b>f</b>) Constructs were transformed into yeast strain AH109, and growth was observed on SD/-Trp and SD/-Trp/-His/-Ade/x-α-Gal.</p>
Full article ">Figure 4
<p>DAP-seq profile of BpWRKY49. (<b>a</b>) The BpWRKY49 transcription factor binding sites across two technical replicates. (<b>b</b>) The distance between the peak center and the TSS of the gene. (<b>c</b>) The BpWRKY49 binding peak distribution in 14 chromosomes. (<b>d</b>) DAP sequencing depth distribution of BpWRKY49. (<b>e</b>) The significantly enriched motif sequence of BpWRKY49 binding sites.</p>
Full article ">Figure 5
<p>GO enrichment and KEGG enrichment analysis of peaks of BpWRKY49. (<b>a</b>) GO enrichment map of targets of BpWRKY49 identified by DAP-seq. (<b>b</b>) KEGG enrichment map of target of BpWRKY49 identified by DAP-seq. (<b>c</b>) GO enrichment analysis of targets of BpWRKY49 showing most enriched GO terms. (<b>d</b>) KEGG enrichment analysis of targets of BpWRKY49 showing the most enriched KEGG terms.</p>
Full article ">Figure 6
<p>Binding of BpWRKY49 to the promoter of target genes using Y1H system. (<b>a</b>) Distribution of W-box elements in the promoter of <span class="html-italic">BpPUB21</span>, <span class="html-italic">BpBTL15,</span> and <span class="html-italic">BpHIP47</span> genes. (<b>b</b>) Yeast cells with promoter fragments of three genes ligated into pAbAi vector were used as bait. pGADT7-BpWRKY49 was transformed independently into yeast cells carrying bait plasmids and were allowed to grow on SD/-Leu (<b>left</b>) and SD/-Leu with AbA (<b>right</b>); 1, 2, 3 show three replicates for each transformant.</p>
Full article ">
25 pages, 13938 KiB  
Article
Cisplatin and Starvation Differently Sensitize Autophagy in Renal Carcinoma: A Potential Therapeutic Pathway to Target Variegated Drugs Resistant Cancerous Cells
by Ankita Dutta, Subarna Thakur, Debasish Kumar Dey and Anoop Kumar
Cells 2024, 13(6), 471; https://doi.org/10.3390/cells13060471 - 7 Mar 2024
Viewed by 1361
Abstract
Cisplatin, a powerful chemotherapy medication, has long been a cornerstone in the fight against cancer due to chemotherapeutic failure. The mechanism of cisplatin resistance/failure is a multifaceted and complex issue that consists mainly of apoptosis inhibition through autophagy sensitization. Currently, researchers are exploring [...] Read more.
Cisplatin, a powerful chemotherapy medication, has long been a cornerstone in the fight against cancer due to chemotherapeutic failure. The mechanism of cisplatin resistance/failure is a multifaceted and complex issue that consists mainly of apoptosis inhibition through autophagy sensitization. Currently, researchers are exploring ways to regulate autophagy in order to tip the balance in favor of effective chemotherapy. Based on this notion, the current study primarily identifies the differentially expressed genes (DEGs) in cisplatin-treated autophagic ACHN cells through the Illumina Hi-seq platform. A protein–protein interaction network was constructed using the STRING database and KEGG. GO classifiers were implicated to identify genes and their participating biological pathways. ClueGO, David, and MCODE detected ontological enrichment and sub-networking. The network topology was further examined using 12 different algorithms to identify top-ranked hub genes through the Cytoscape plugin Cytohubba to identify potential targets, which established profound drug efficacy under an autophagic environment. Considerable upregulation of genes related to autophagy and apoptosis suggests that autophagy boosts cisplatin efficacy in malignant ACHN cells with minimal harm to normal HEK-293 growth. Furthermore, the determination of cellular viability and apoptosis by AnnexinV/FITC-PI assay corroborates with in silico data, indicating the reliability of the bioinformatics method followed by qRT-PCR. Altogether, our data provide a clear molecular insight into drug efficacy under starved conditions to improve chemotherapy and will likely prompt more clinical trials on this aspect. Full article
(This article belongs to the Special Issue Molecular Mechanisms and Biological Roles of Alternative Autophagy)
Show Figures

Figure 1

Figure 1
<p>Effect of cisplatin in starvation-induced autophagic cell lines. (<b>A</b>) Autophagosomes were detected by CYTO-ID autophagy detection kit in nutrient-deficient normal (HEK-293) and cancer cell (ACHN) lines. Cells were treated in the presence of complete media (CM), PBS (autophagy inducer), and rapamycin (positive control) in both cell lines. (<b>B</b>) Antibody-based indirect ELISA was used to assess autophagy progression in control (cells without treatment) and in PBS-treated (nutrient-deprived for 3 h) cells. The cytosolic protein was extracted from each treatment condition from both cell lines, and quantification of autophagy-related biomarkers was achieved by recording absorbance at 450 nm using SPECTROStar Nano plate reader (BMG Labteck, Germany). (<b>C</b>) Percentage of cell viability after cisplatin treatment in HEK-293 and ACHN cell by MTT assay after 24 h. (<b>D</b>) Trypan blue exclusion assay for precise quantification of viable and non-viable cells in all conditions—control, PBS (without nutrient), control + cisplatin, and PBS + cisplatin (starvation-induced autophagic condition + cisplatin). All data are mean ± SD and are indicative of three separate studies. The significance level was set at <span class="html-italic">p</span> &lt; 0.05 (*: <span class="html-italic">p</span> ≤ 0.05, **: <span class="html-italic">p</span> ≤ 0.01, ***: <span class="html-italic">p</span> ≤ 0.001, ****: <span class="html-italic">p</span> ≤ 0.0001), and the standard deviations of the data were displayed as error bars.</p>
Full article ">Figure 1 Cont.
<p>Effect of cisplatin in starvation-induced autophagic cell lines. (<b>A</b>) Autophagosomes were detected by CYTO-ID autophagy detection kit in nutrient-deficient normal (HEK-293) and cancer cell (ACHN) lines. Cells were treated in the presence of complete media (CM), PBS (autophagy inducer), and rapamycin (positive control) in both cell lines. (<b>B</b>) Antibody-based indirect ELISA was used to assess autophagy progression in control (cells without treatment) and in PBS-treated (nutrient-deprived for 3 h) cells. The cytosolic protein was extracted from each treatment condition from both cell lines, and quantification of autophagy-related biomarkers was achieved by recording absorbance at 450 nm using SPECTROStar Nano plate reader (BMG Labteck, Germany). (<b>C</b>) Percentage of cell viability after cisplatin treatment in HEK-293 and ACHN cell by MTT assay after 24 h. (<b>D</b>) Trypan blue exclusion assay for precise quantification of viable and non-viable cells in all conditions—control, PBS (without nutrient), control + cisplatin, and PBS + cisplatin (starvation-induced autophagic condition + cisplatin). All data are mean ± SD and are indicative of three separate studies. The significance level was set at <span class="html-italic">p</span> &lt; 0.05 (*: <span class="html-italic">p</span> ≤ 0.05, **: <span class="html-italic">p</span> ≤ 0.01, ***: <span class="html-italic">p</span> ≤ 0.001, ****: <span class="html-italic">p</span> ≤ 0.0001), and the standard deviations of the data were displayed as error bars.</p>
Full article ">Figure 2
<p>(<b>A</b>) Hierarchical clustering of differentially expressed up−regulated and (<b>B</b>) down−regulated genes in autophagic-treated (cisplatin-treated autophagic ACHN) and autophagic non-treated ACHN (control) cell lines. Heat−map was generated by TBtools (<a href="https://github.com/CJ-Chen/TBtools/releases" target="_blank">https://github.com/CJ-Chen/TBtools/releases</a>) with the FPKM (fragments per kilobase of transcript per million mapped reads) value of both samples. (<b>C</b>) Cnet plot of genes regulating major biological processes (BP); (<b>D</b>) Cnet plot of major cellular components involved (CC); (<b>E</b>) Cnet plot of major molecular function (MF)-regulating genes. The plots were generated by SRPLOT (<a href="http://www.bioinformatics.com.cn/srplot" target="_blank">http://www.bioinformatics.com.cn/srplot</a>) based on the results of the enriched KEGG pathway. Size = number of differentially expressed genes in the enriched KEGG pathway; fold change = the fold change difference between cisplatin-treated autophagic ACHNs and non-treated autophagic ACHNs. (<b>F</b>) Bubble plot showing GO results of all three ontologies ((<b>a</b>–<b>c</b>): bubble plot showing significant pathways for up-regulated DEGs in terms of BP, CC, MF respectively. Larger bubbles indicate higher number of genes. The colour of each bubble reflects significance; (<b>d</b>): combined GO results of three different ontologies) with defined enrichment score.</p>
Full article ">Figure 2 Cont.
<p>(<b>A</b>) Hierarchical clustering of differentially expressed up−regulated and (<b>B</b>) down−regulated genes in autophagic-treated (cisplatin-treated autophagic ACHN) and autophagic non-treated ACHN (control) cell lines. Heat−map was generated by TBtools (<a href="https://github.com/CJ-Chen/TBtools/releases" target="_blank">https://github.com/CJ-Chen/TBtools/releases</a>) with the FPKM (fragments per kilobase of transcript per million mapped reads) value of both samples. (<b>C</b>) Cnet plot of genes regulating major biological processes (BP); (<b>D</b>) Cnet plot of major cellular components involved (CC); (<b>E</b>) Cnet plot of major molecular function (MF)-regulating genes. The plots were generated by SRPLOT (<a href="http://www.bioinformatics.com.cn/srplot" target="_blank">http://www.bioinformatics.com.cn/srplot</a>) based on the results of the enriched KEGG pathway. Size = number of differentially expressed genes in the enriched KEGG pathway; fold change = the fold change difference between cisplatin-treated autophagic ACHNs and non-treated autophagic ACHNs. (<b>F</b>) Bubble plot showing GO results of all three ontologies ((<b>a</b>–<b>c</b>): bubble plot showing significant pathways for up-regulated DEGs in terms of BP, CC, MF respectively. Larger bubbles indicate higher number of genes. The colour of each bubble reflects significance; (<b>d</b>): combined GO results of three different ontologies) with defined enrichment score.</p>
Full article ">Figure 2 Cont.
<p>(<b>A</b>) Hierarchical clustering of differentially expressed up−regulated and (<b>B</b>) down−regulated genes in autophagic-treated (cisplatin-treated autophagic ACHN) and autophagic non-treated ACHN (control) cell lines. Heat−map was generated by TBtools (<a href="https://github.com/CJ-Chen/TBtools/releases" target="_blank">https://github.com/CJ-Chen/TBtools/releases</a>) with the FPKM (fragments per kilobase of transcript per million mapped reads) value of both samples. (<b>C</b>) Cnet plot of genes regulating major biological processes (BP); (<b>D</b>) Cnet plot of major cellular components involved (CC); (<b>E</b>) Cnet plot of major molecular function (MF)-regulating genes. The plots were generated by SRPLOT (<a href="http://www.bioinformatics.com.cn/srplot" target="_blank">http://www.bioinformatics.com.cn/srplot</a>) based on the results of the enriched KEGG pathway. Size = number of differentially expressed genes in the enriched KEGG pathway; fold change = the fold change difference between cisplatin-treated autophagic ACHNs and non-treated autophagic ACHNs. (<b>F</b>) Bubble plot showing GO results of all three ontologies ((<b>a</b>–<b>c</b>): bubble plot showing significant pathways for up-regulated DEGs in terms of BP, CC, MF respectively. Larger bubbles indicate higher number of genes. The colour of each bubble reflects significance; (<b>d</b>): combined GO results of three different ontologies) with defined enrichment score.</p>
Full article ">Figure 2 Cont.
<p>(<b>A</b>) Hierarchical clustering of differentially expressed up−regulated and (<b>B</b>) down−regulated genes in autophagic-treated (cisplatin-treated autophagic ACHN) and autophagic non-treated ACHN (control) cell lines. Heat−map was generated by TBtools (<a href="https://github.com/CJ-Chen/TBtools/releases" target="_blank">https://github.com/CJ-Chen/TBtools/releases</a>) with the FPKM (fragments per kilobase of transcript per million mapped reads) value of both samples. (<b>C</b>) Cnet plot of genes regulating major biological processes (BP); (<b>D</b>) Cnet plot of major cellular components involved (CC); (<b>E</b>) Cnet plot of major molecular function (MF)-regulating genes. The plots were generated by SRPLOT (<a href="http://www.bioinformatics.com.cn/srplot" target="_blank">http://www.bioinformatics.com.cn/srplot</a>) based on the results of the enriched KEGG pathway. Size = number of differentially expressed genes in the enriched KEGG pathway; fold change = the fold change difference between cisplatin-treated autophagic ACHNs and non-treated autophagic ACHNs. (<b>F</b>) Bubble plot showing GO results of all three ontologies ((<b>a</b>–<b>c</b>): bubble plot showing significant pathways for up-regulated DEGs in terms of BP, CC, MF respectively. Larger bubbles indicate higher number of genes. The colour of each bubble reflects significance; (<b>d</b>): combined GO results of three different ontologies) with defined enrichment score.</p>
Full article ">Figure 3
<p>(<b>A</b>) Protein–protein interaction network constructed using STRING (Search Tool for the Retrieval of Interacting Genes/Proteins, version 11.5; <a href="https://string-db.org" target="_blank">https://string-db.org</a>) with significantly upregulated DEGs in autophagic ACHNs in response to cisplatin. (<b>B</b>) Pathway network constructed using all the upregulated DEGs (<b>a</b>); Pie chart shows all the significantly up-regulated pathways (<b>b</b>). (<b>C</b>) Constructed pathway network from MCODE Cluster 1 generated using Cytoscape plugin ClueGO (<b>a</b>); pie chart shows the stress associated with overexpressed functional categories of the ClueGo pathway analysis (<b>b</b>). (<b>D</b>) Constructed pathway network from MCODE Cluster 2 generated using Cytoscape plugin ClueGO (<b>a</b>); pie chart shows the autophagy- and apoptosis-associated overexpressed functional categories of ClueGo (<b>b</b>) pathway analysis (** <span class="html-italic">p</span> &lt; 0.001). The significantly enriched pathways are denoted by different colors.</p>
Full article ">Figure 3 Cont.
<p>(<b>A</b>) Protein–protein interaction network constructed using STRING (Search Tool for the Retrieval of Interacting Genes/Proteins, version 11.5; <a href="https://string-db.org" target="_blank">https://string-db.org</a>) with significantly upregulated DEGs in autophagic ACHNs in response to cisplatin. (<b>B</b>) Pathway network constructed using all the upregulated DEGs (<b>a</b>); Pie chart shows all the significantly up-regulated pathways (<b>b</b>). (<b>C</b>) Constructed pathway network from MCODE Cluster 1 generated using Cytoscape plugin ClueGO (<b>a</b>); pie chart shows the stress associated with overexpressed functional categories of the ClueGo pathway analysis (<b>b</b>). (<b>D</b>) Constructed pathway network from MCODE Cluster 2 generated using Cytoscape plugin ClueGO (<b>a</b>); pie chart shows the autophagy- and apoptosis-associated overexpressed functional categories of ClueGo (<b>b</b>) pathway analysis (** <span class="html-italic">p</span> &lt; 0.001). The significantly enriched pathways are denoted by different colors.</p>
Full article ">Figure 3 Cont.
<p>(<b>A</b>) Protein–protein interaction network constructed using STRING (Search Tool for the Retrieval of Interacting Genes/Proteins, version 11.5; <a href="https://string-db.org" target="_blank">https://string-db.org</a>) with significantly upregulated DEGs in autophagic ACHNs in response to cisplatin. (<b>B</b>) Pathway network constructed using all the upregulated DEGs (<b>a</b>); Pie chart shows all the significantly up-regulated pathways (<b>b</b>). (<b>C</b>) Constructed pathway network from MCODE Cluster 1 generated using Cytoscape plugin ClueGO (<b>a</b>); pie chart shows the stress associated with overexpressed functional categories of the ClueGo pathway analysis (<b>b</b>). (<b>D</b>) Constructed pathway network from MCODE Cluster 2 generated using Cytoscape plugin ClueGO (<b>a</b>); pie chart shows the autophagy- and apoptosis-associated overexpressed functional categories of ClueGo (<b>b</b>) pathway analysis (** <span class="html-italic">p</span> &lt; 0.001). The significantly enriched pathways are denoted by different colors.</p>
Full article ">Figure 3 Cont.
<p>(<b>A</b>) Protein–protein interaction network constructed using STRING (Search Tool for the Retrieval of Interacting Genes/Proteins, version 11.5; <a href="https://string-db.org" target="_blank">https://string-db.org</a>) with significantly upregulated DEGs in autophagic ACHNs in response to cisplatin. (<b>B</b>) Pathway network constructed using all the upregulated DEGs (<b>a</b>); Pie chart shows all the significantly up-regulated pathways (<b>b</b>). (<b>C</b>) Constructed pathway network from MCODE Cluster 1 generated using Cytoscape plugin ClueGO (<b>a</b>); pie chart shows the stress associated with overexpressed functional categories of the ClueGo pathway analysis (<b>b</b>). (<b>D</b>) Constructed pathway network from MCODE Cluster 2 generated using Cytoscape plugin ClueGO (<b>a</b>); pie chart shows the autophagy- and apoptosis-associated overexpressed functional categories of ClueGo (<b>b</b>) pathway analysis (** <span class="html-italic">p</span> &lt; 0.001). The significantly enriched pathways are denoted by different colors.</p>
Full article ">Figure 4
<p>Sequential workflow of bioinformatics analysis pipeline. Flowchart describing the steps of data processing and subsequent analysis of differentially expressed genes.</p>
Full article ">Figure 5
<p>(<b>A</b>) Validation of RNAseq data by measuring the relative expression level of 10 differentially expressed genes in the ACHN cell line in control (autophagic ACHN cells without cisplatin) and treated (cisplatin-treated autophagic ACHN cells) cell lines by qRT-PCR. Values are represented as ±SD of at least three independent experiments. <span class="html-italic">p</span> &lt; 0.05 was considered significant (**: <span class="html-italic">p</span> ≤ 0.01, ***: <span class="html-italic">p</span> ≤ 0.001, ****: <span class="html-italic">p</span> ≤ 0.0001); the standard deviations of the data have been shown in the form of error bars. (<b>B</b>) Cell death was recorded in HEK-293 and ACHN cells through annexin V-FITC/PI assay—HEK-293 and ACHN cells were treated with cisplatin in nutrient-sufficient (control + cisplatin) and nutrient-deficient conditions (PBS + cisplatin). Slides were stained according to the manufacturer’s instructions, and visualization was achieved under the 40× objective of a fluorescence microscope (Magnus MLXi, India). Each image is a representative of at least three independent biological experiments.</p>
Full article ">
16 pages, 1186 KiB  
Article
Merging Ontologies and Data from Electronic Health Records
by Salvatore Calcagno, Andrea Calvagna, Emiliano Tramontana and Gabriella Verga
Future Internet 2024, 16(2), 62; https://doi.org/10.3390/fi16020062 - 17 Feb 2024
Cited by 1 | Viewed by 1458
Abstract
The Electronic Health Record (EHR) is a system for collecting and storing patient medical records as data that can be mechanically accessed, hence facilitating and assisting the medical decision-making process. EHRs exist in several formats, and each format lists thousands of keywords to [...] Read more.
The Electronic Health Record (EHR) is a system for collecting and storing patient medical records as data that can be mechanically accessed, hence facilitating and assisting the medical decision-making process. EHRs exist in several formats, and each format lists thousands of keywords to classify patients data. The keywords are specific and are medical jargon; hence, data classification is very accurate. As the keywords constituting the formats of medical records express concepts by means of specific jargon without definitions or references, their proper use is left to clinicians and could be affected by their background, hence the interpretation of data could become slow or less accurate than that desired. This article presents an approach that accurately relates data in EHRs to ontologies in the medical realm. Thanks to ontologies, clinicians can be assisted when writing or analysing health records, e.g., our solution promptly suggests rigorous definitions for scientific terms, and automatically connects data spread over several parts of EHRs. The first step of our approach consists of converting selected data and keywords from several EHR formats into a format easier to parse, then the second step is merging the extracted data with specialised medical ontologies. Finally, enriched versions of the medical data are made available to professionals. The proposed approach was validated by taking samples of medical records and ontologies in the real world. The results have shown both versatility on handling data, precision of query results, and appropriate suggestions for relations among medical records. Full article
Show Figures

Figure 1

Figure 1
<p>Snippet of XML code displaying intrinsic syntactic complexity despite being extracted from a simple, basic example of CDA document. Points marked 1 to 4 highlight the following tags: root, codeSystem, code, and ID, respectively.</p>
Full article ">Figure 2
<p>Comparison of two XML files with different structures but the same type of content.</p>
Full article ">Figure 3
<p>On the <b>left</b>, the main branches of the Human Disease Ontology and on the <b>right</b> some classes that derive from the first disease, or disease by infectious agent.</p>
Full article ">Figure 4
<p>A representation of the class penicillin allergy found in HDO.</p>
Full article ">Figure 5
<p>A representation of the class anaphylactic shock found in HDO.</p>
Full article ">Figure 6
<p>Example of a patient’s medical record with ID 444222222, showing data taken from three HL7 CDA files (centre) and HDO ontology (accessed on 10 November 2023).</p>
Full article ">
34 pages, 3406 KiB  
Article
Evaluating Ontology-Based PD Monitoring and Alerting in Personal Health Knowledge Graphs and Graph Neural Networks
by Nikolaos Zafeiropoulos, Pavlos Bitilis, George E. Tsekouras and Konstantinos Kotis
Information 2024, 15(2), 100; https://doi.org/10.3390/info15020100 - 8 Feb 2024
Cited by 3 | Viewed by 1901
Abstract
In the realm of Parkinson’s Disease (PD) research, the integration of wearable sensor data with personal health records (PHR) has emerged as a pivotal avenue for patient alerting and monitoring. This study delves into the complex domain of PD patient care, with a [...] Read more.
In the realm of Parkinson’s Disease (PD) research, the integration of wearable sensor data with personal health records (PHR) has emerged as a pivotal avenue for patient alerting and monitoring. This study delves into the complex domain of PD patient care, with a specific emphasis on harnessing the potential of wearable sensors to capture, represent and semantically analyze crucial movement data and knowledge. The primary objective is to enhance the assessment of PD patients by establishing a robust foundation for personalized health insights through the development of Personal Health Knowledge Graphs (PHKGs) and the employment of personal health Graph Neural Networks (PHGNNs) that utilize PHKGs. The objective is to formalize the representation of related integrated data, unified sensor and PHR data in higher levels of abstraction, i.e., in a PHKG, to facilitate interoperability and support rule-based high-level event recognition such as patient’s missing dose or falling. This paper, extending our previous related work, presents the Wear4PDmove ontology in detail and evaluates the ontology within the development of an experimental PHKG. Furthermore, this paper focuses on the integration and evaluation of PHKG within the implementation of a Graph Neural Network (GNN). This work emphasizes the importance of integrating PD-related data for monitoring and alerting patients with appropriate notifications. These notifications offer health experts precise and timely information for the continuous evaluation of personal health-related events, ultimately contributing to enhanced patient care and well-informed medical decision-making. Finally, the paper concludes by proposing a novel approach for integrating personal health KGs and GNNs for PD monitoring and alerting solutions. Full article
(This article belongs to the Special Issue Knowledge Graph Technology and its Applications II)
Show Figures

Figure 1

Figure 1
<p>Wear4PDmove ontology key concepts and the reused vocabularies.</p>
Full article ">Figure 2
<p>Example of RDF triples representing related knowledge of a PD patient observation.</p>
Full article ">Figure 3
<p>Knowledge Graph integrating the Wear4PDmove ontology.</p>
Full article ">Figure 4
<p>SPARQL query in the Python environment.</p>
Full article ">Figure 5
<p>Resulting triples from the CONSTRUCT query.</p>
Full article ">Figure 6
<p>Personal Health Graph Neural Network (PHGNN) architecture.</p>
Full article ">Figure 7
<p>Model performance metrics for medium and high alert predictions across training epochs, including loss and accuracy values.</p>
Full article ">Figure 8
<p>Loss medium alert in different hidden layers.</p>
Full article ">Figure 9
<p>Loss of high alert in different hidden layers.</p>
Full article ">Figure 10
<p>Model training progress: Loss values over epochs for different hidden channels.</p>
Full article ">
Back to TopTop